As the global economy mends, the 2021 growth of Human Interleukin-2 (IL-2) will have significant change from previous year. According to our (LP Information) latest study, the global Human Interleukin-2 (IL-2) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Interleukin-2 (IL-2) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Human Interleukin-2 (IL-2) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Interleukin-2 (IL-2) market, reaching US$ million by the year 2028. As for the Europe Human Interleukin-2 (IL-2) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Interleukin-2 (IL-2) players cover Roche, BMS, Schering-Plough, and AbbVie Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Interleukin-2 (IL-2) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
50000 U
100000 U
200000 U
500000 U
1 Million U
2 Million U
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Recombinant Interferon
Recombinant Interleukin
Natural Biological Products
Poison Immune
Gene Therapy
Monoclonal Antibody
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
BMS
Schering-Plough
AbbVie Inc
Alkermes Plc
APT Therapeutics
Mabtech Limited
Philogen
Sinopharm
Jiangsu Jinsili Pharmaceutical
Shenyang Sansheng Pharmaceutical
Beijing Shuanglu Pharmaceutical
Shandong Quangang Pharmaceutical
Shanghai Huaxin Biological high-tech
Beijing Yuance Pharmaceutical
Beijing Sihuan Biological Pharmaceutical
Beijing Sanyuan Gene Pharmaceutical
Shenzhen Kexing Biological Engineering
Shanghai Sanwei Biotechnology
Xiamen Tebao Biological Engineering
Chengdu huashen Biotechnology
Shanghai Pharma Group
Guangdong Xinghao Pharmaceutical